Skip to main content

Health economic modeling for medical technologies in Europe

Early and comprehensive economic models to determine economic value proposition and inform healthcare decision-makers

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Three more health apps obtained reimbursement in Germany

On December 26, 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by sickness funds.

The “®” reimbursable health app was introduced in the Directory. The “®”, developed by SOFY GmbH, Austria, consists of the® system, with® psychoeducation and® mood diagram. The system is a web-based software that can be called up and accessed from any platform using standard browsers with an Internet connection (Software-as-a-Service). The application guides the patients with dep through the program along the "Activity Feeds" and plays out multimedia information and exercises from psychodeduction for self-help daily. It also contains elements of computer-based cognitive behavioral therapy. The app is available in German and English with a tariff of €357 (first subscription) and €178.50 (renewal of the subscription).

“elona therapy depression”, developed by Elona Health GmbH, Germany, is a digital health app for outpatient psychotherapy that intelligently combines digital interventions and regular talk therapy, thus supporting the treatment of unipolar depression. Patients have access to tailored psychotherapeutic resources between therapy sessions, including interventions, activities, exercises, and psychoeducational content. The app is available in German with a tariff of €535.49.

“Kaia COPD”, developed by kaia health software GmbH, is a digital app for adult patients with chronic obstructive pulmonary disease (COPD), developed together with pulmonologists. It conveys evidence-based and guideline-compliant content of pulmonary rehabilitation to improve physical performance and health-related quality of life. “Kaia COPD” consists of the following therapy elements: movement, patient education as well as relaxation, and breathing techniques. The contents are based on the recommendations of the National COPD Care Guideline. The app is available in German and English with a tariff of €415.

The full details in German can be found here (®), here (elona therapy depression), and here (Kaia COPD).

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.